LDLR rs1057519659: Understanding Familial Hypercholesterolemia Risk

What each genotype means

What is rs1057519659?

The variant rs1057519659 is a specific change in the DNA sequence located on chromosome 19. In genetic databases, this variant is often described as a deletion, specifically involving the sequence AATCTGACGA. Because it is a structural change rather than a simple single-letter swap, it can significantly alter the way the body reads the genetic instructions at this location. It is categorized as a health-predisposition variant, meaning its presence is statistically linked to a higher likelihood of developing certain clinical traits. Researchers track these variants to better understand how specific DNA sequences contribute to human health and disease susceptibility.

The Role of the LDLR Gene

The LDLR gene provides instructions for making the low-density lipoprotein receptor protein. These receptors are found on the surface of cells, particularly in the liver, where they act like docking stations to remove LDL cholesterol—often called 'bad' cholesterol—from the bloodstream. When the LDLR gene functions correctly, these receptors help maintain healthy cholesterol levels. However, when variants occur in this gene, the receptors may be produced in insufficient numbers or may not function properly. This leads to an accumulation of LDL cholesterol in the blood, which is a hallmark of familial hypercholesterolemia. Understanding this gene is essential for grasping how genetic factors influence cardiovascular health.

Research and Clinical Evidence

Scientific research, including data curated by the ClinGen Familial Hypercholesterolemia Variant Curation Expert Panel, has identified thousands of variants in the LDLR gene that contribute to familial hypercholesterolemia. The variant rs1057519659 has been documented in clinical databases like ClinVar, where it is associated with the clinical presentation of this condition. The evidence for such variants is typically evaluated using standardized guidelines from the American College of Medical Genetics and Genomics (ACMG). These guidelines look at factors like how often the variant appears in affected individuals compared to the general population and whether the variant co-segregates with the disease within families. While the association is recognized, clinical interpretation of any specific variant should always be performed by a qualified healthcare professional.

Population Frequency and Interpretation

Information regarding the frequency of rs1057519659 across different global populations is currently limited in public databases. Many rare variants associated with familial hypercholesterolemia are found at very low frequencies in the general population, often appearing as 'founder' mutations in specific communities or families. Because this variant is not common, it is not typically included in standard, broad-spectrum genetic screening panels. If you have received information about this variant, it is important to remember that genetic testing results are only one piece of a larger health puzzle. Lifestyle factors, diet, and other genetic markers also play significant roles in cholesterol levels and overall cardiovascular risk.

Managing Genetic Information

If you are concerned about your cholesterol levels or a family history of heart disease, the most important step is to consult with a physician or a genetic counselor. Genetic information regarding variants like rs1057519659 should never be used to self-diagnose or to make changes to prescribed medications. A clinician can interpret these results in the context of your personal medical history, physical exams, and standard blood lipid panels. They can provide guidance on whether further testing is necessary and discuss appropriate management strategies, such as dietary adjustments or cholesterol-lowering therapies. Always discuss any genetic findings with a healthcare provider before making decisions about your health.

Frequently asked questions

Sources & further reading

Related variants in LDLR